skip to Main Content

Cancer Services

Skin Cancer

Please see below all current skin cancer clinical trials of the Central Coast Cancer Centre.

Name: SGNLV-005

Open-Label Phase 2 Study of Ladiratuzumab Vedotin (LV) for unresectable locally advanced metastatic
solid tumours.

Principal Investigator: Dr Matthew Wong
Study Coordinator: Bronwyn Raymond
Status: Recruiting
Condition: Melanoma
External page link More information about SGNLV-005

Name: c-POST

A randomized, placebo-controlled, double-blind study of adjuvant Cemiplimab versus placebo after surgery and radiation therapy in patients with high risk cutaneous squamous cell carcinoma.

Principal Investigator: Dr Craig Kukard
Study Coordinator: Cassandra Rubio
Status: Recruiting
Condition: Skin Cancer
External page link More information about c-POST

More information

For more information about medical oncology clinical trials, please contact the Nurse Unit Manager on 02 4320 9890 or see:

Internal page Research and Clinical Trials

Back To Top